Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | STOK |
---|---|---|
09:32 ET | 168708 | 13.88 |
09:34 ET | 74939 | 13.7701 |
09:36 ET | 37329 | 13.755 |
09:38 ET | 34126 | 13.73 |
09:39 ET | 56156 | 13.74 |
09:41 ET | 66878 | 13.3 |
09:43 ET | 212558 | 12.81 |
09:45 ET | 77951 | 12.585 |
09:48 ET | 85536 | 13.09 |
09:50 ET | 35493 | 13.08 |
09:52 ET | 21898 | 12.99 |
09:54 ET | 55492 | 13.225 |
09:56 ET | 8587 | 13.295 |
09:57 ET | 50724 | 13.4 |
09:59 ET | 49342 | 13.455 |
10:01 ET | 22867 | 13.47 |
10:03 ET | 33880 | 13.565 |
10:06 ET | 25473 | 13.43 |
10:08 ET | 22215 | 13.17 |
10:10 ET | 26385 | 13.085 |
10:12 ET | 20796 | 13.15 |
10:14 ET | 21980 | 12.9903 |
10:15 ET | 25266 | 13.1999 |
10:17 ET | 25158 | 13.15 |
10:19 ET | 9298 | 13.21 |
10:21 ET | 8409 | 13.095 |
10:24 ET | 12947 | 13.155 |
10:26 ET | 5113 | 13.09 |
10:28 ET | 13982 | 12.9539 |
10:30 ET | 12982 | 12.91 |
10:32 ET | 23461 | 12.85 |
10:33 ET | 52148 | 13.01 |
10:35 ET | 9002 | 13.025 |
10:37 ET | 13906 | 13.02 |
10:39 ET | 17562 | 13.01 |
10:42 ET | 7589 | 13.0004 |
10:44 ET | 3738 | 13.04 |
10:46 ET | 49706 | 13.13 |
10:48 ET | 7795 | 13.09 |
10:50 ET | 16393 | 13.15 |
10:51 ET | 49515 | 13.33 |
10:53 ET | 20705 | 13.385 |
10:55 ET | 49273 | 13.47 |
10:57 ET | 25750 | 13.4 |
11:00 ET | 16858 | 13.39 |
11:02 ET | 31924 | 13.49 |
11:04 ET | 10579 | 13.3447 |
11:06 ET | 9502 | 13.315 |
11:08 ET | 5453 | 13.37 |
11:09 ET | 2583 | 13.375 |
11:11 ET | 1976 | 13.395 |
11:13 ET | 2299 | 13.385 |
11:15 ET | 5267 | 13.4 |
11:18 ET | 12710 | 13.435 |
11:20 ET | 4697 | 13.42 |
11:22 ET | 13515 | 13.33 |
11:24 ET | 8851 | 13.34 |
11:26 ET | 5051 | 13.375 |
11:27 ET | 2159 | 13.375 |
11:29 ET | 4545 | 13.385 |
11:31 ET | 1905 | 13.375 |
11:33 ET | 19698 | 13.23 |
11:36 ET | 7538 | 13.27 |
11:38 ET | 2500 | 13.3 |
11:40 ET | 15049 | 13.275 |
11:42 ET | 5300 | 13.28 |
11:44 ET | 13001 | 13.265 |
11:45 ET | 8800 | 13.3 |
11:47 ET | 15000 | 13.31 |
11:49 ET | 1300 | 13.3 |
11:51 ET | 5424 | 13.3 |
11:54 ET | 11748 | 13.36 |
11:56 ET | 5713 | 13.36 |
11:58 ET | 2954 | 13.38 |
12:00 ET | 6957 | 13.365 |
12:02 ET | 6630 | 13.41 |
12:03 ET | 1800 | 13.41 |
12:05 ET | 2749 | 13.3902 |
12:07 ET | 13289 | 13.3003 |
12:09 ET | 23526 | 13.3 |
12:12 ET | 16076 | 13.3 |
12:14 ET | 12013 | 13.31 |
12:16 ET | 34635 | 13.32 |
12:18 ET | 5439 | 13.32 |
12:20 ET | 4470 | 13.315 |
12:21 ET | 1766 | 13.31 |
12:23 ET | 1766 | 13.3 |
12:25 ET | 3412 | 13.305 |
12:27 ET | 5668 | 13.32 |
12:30 ET | 4350 | 13.31 |
12:32 ET | 4242 | 13.3 |
12:34 ET | 3439 | 13.3 |
12:36 ET | 1500 | 13.3 |
12:38 ET | 766 | 13.3 |
12:39 ET | 1396 | 13.3 |
12:41 ET | 2552 | 13.3 |
12:43 ET | 11981 | 13.305 |
12:45 ET | 5824 | 13.3094 |
12:48 ET | 22596 | 13.13 |
12:50 ET | 11126 | 13.03 |
12:52 ET | 11085 | 12.91 |
12:54 ET | 10210 | 12.9701 |
12:56 ET | 4991 | 12.93 |
12:57 ET | 9505 | 12.84 |
12:59 ET | 24084 | 12.94 |
01:01 ET | 6438 | 12.87 |
01:03 ET | 13255 | 12.92 |
01:06 ET | 7776 | 12.85 |
01:08 ET | 12311 | 12.7847 |
01:10 ET | 17852 | 12.85 |
01:12 ET | 1160 | 12.7851 |
01:14 ET | 5659 | 12.87 |
01:15 ET | 10988 | 12.85 |
01:17 ET | 3893 | 12.92 |
01:19 ET | 15927 | 12.93 |
01:21 ET | 8851 | 13 |
01:24 ET | 3296 | 12.9625 |
01:26 ET | 7920 | 12.99 |
01:28 ET | 8575 | 12.99 |
01:30 ET | 6777 | 13 |
01:32 ET | 1600 | 12.985 |
01:33 ET | 2400 | 12.98 |
01:35 ET | 25220 | 13.06 |
01:37 ET | 600 | 13.05 |
01:39 ET | 4658 | 13.1 |
01:42 ET | 11873 | 13.06 |
01:44 ET | 29742 | 13.04 |
01:46 ET | 26954 | 12.98 |
01:48 ET | 17911 | 12.965 |
01:50 ET | 5953 | 13.08 |
01:51 ET | 700 | 12.9914 |
01:53 ET | 200 | 13 |
01:55 ET | 2586 | 12.99 |
01:57 ET | 639 | 13.03 |
02:00 ET | 4886 | 13.03 |
02:02 ET | 5729 | 13.04 |
02:04 ET | 3568 | 13 |
02:06 ET | 19311 | 13 |
02:08 ET | 3008 | 13.03 |
02:09 ET | 400 | 13.05 |
02:11 ET | 871 | 13.07 |
02:13 ET | 1110 | 13.05 |
02:15 ET | 56013 | 13.13 |
02:18 ET | 3490 | 13.07 |
02:20 ET | 2377 | 13.06 |
02:22 ET | 3387 | 13.02 |
02:24 ET | 4660 | 13.0122 |
02:26 ET | 500 | 13.03 |
02:27 ET | 37260 | 13.225 |
02:29 ET | 9684 | 13.22 |
02:31 ET | 17962 | 13.2164 |
02:33 ET | 1957 | 13.17 |
02:36 ET | 5988 | 13.11 |
02:38 ET | 9793 | 13.15 |
02:40 ET | 5280 | 13.16 |
02:42 ET | 3357 | 13.16 |
02:44 ET | 3300 | 13.155 |
02:45 ET | 8743 | 13.18 |
02:47 ET | 11229 | 13.12 |
02:49 ET | 1738 | 13.0601 |
02:51 ET | 11300 | 13 |
02:54 ET | 26018 | 13.15 |
02:56 ET | 800 | 13.1599 |
02:58 ET | 7153 | 13.19 |
03:00 ET | 2260 | 13.19 |
03:02 ET | 5530 | 13.265 |
03:03 ET | 4092 | 13.26 |
03:05 ET | 30474 | 13.33 |
03:07 ET | 8753 | 13.29 |
03:09 ET | 2600 | 13.25 |
03:12 ET | 3220 | 13.18 |
03:14 ET | 21235 | 13.1102 |
03:16 ET | 11900 | 13.0808 |
03:18 ET | 5301 | 13.15 |
03:20 ET | 1000 | 13.16 |
03:21 ET | 3775 | 13.16 |
03:23 ET | 3409 | 13.065 |
03:25 ET | 11884 | 13.035 |
03:27 ET | 13906 | 13.015 |
03:30 ET | 9623 | 13.04 |
03:32 ET | 1766 | 13.0403 |
03:34 ET | 16956 | 13.08 |
03:36 ET | 7393 | 13 |
03:38 ET | 9578 | 13.015 |
03:39 ET | 5973 | 13.07 |
03:41 ET | 5867 | 13.095 |
03:43 ET | 16053 | 13.2 |
03:45 ET | 21444 | 13.18 |
03:48 ET | 27411 | 13.15 |
03:50 ET | 42710 | 13.19 |
03:52 ET | 83741 | 13.3374 |
03:54 ET | 55370 | 13.3 |
03:56 ET | 63132 | 13.15 |
03:57 ET | 98261 | 13.26 |
03:59 ET | 353772 | 13.5 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Stoke Therapeutics Inc | 656.1M | -5.7x | --- |
Absci Corp | 624.8M | -4.7x | --- |
ACELYRIN Inc | 657.0M | 0.0x | --- |
Phathom Pharmaceuticals Inc | 646.2M | -2.7x | --- |
Mind Medicine (MindMed) Inc | 667.5M | -3.8x | --- |
Savara Inc | 670.0M | -14.5x | --- |
Stoke Therapeutics, Inc. is a biotechnology company focused on addressing the underlying causes of severe genetic diseases by upregulating protein expression with ribonucleic acid-based medicines. Using its Targeted Augmentation of Nuclear Gene Output (TANGO) approach, the Company is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. STK-001 is designed to upregulate NaV1.1 protein expression by leveraging the non-mutant (wild-type) copy of the SCN1A gene to restore physiological NaV1.1 levels, thereby reducing both the occurrence of seizures and non-seizure comorbidities. Its STK-002 is a ASO in preclinical development for the treatment of Autosomal Dominant Optic Atrophy (ADOA). STK-002 is designed to upregulate OPA1 protein expression by leveraging the non-mutant (wild-type) copy of the OPA1 gene.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $656.1M |
---|---|
Revenue (TTM) | $8.8M |
Shares Outstanding | 46.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.77 |
EPS | $-2.38 |
Book Value | $3.47 |
P/E Ratio | -5.7x |
Price/Sales (TTM) | 74.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,307.05% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.